-
Antibiotic induced changes to mitochondria result in potential contributions to carcinogenesis.
Jorma Jyrkkanen
Commentary: Clinical Investigation
-
Antibiotic induced changes to mitochondria result in potential contributions to carcinogenesis.
Jorma Jyrkkanen
Commentary: Clinical Investigation
-
Antibiotic induced changes to mitochondria result in potential contributions to carcinogenesis.
Jorma Jyrkkanen
Commentary: Clinical Investigation
-
Antibiotic induced changes to mitochondria result in potential contributions to carcinogenesis.
Jorma Jyrkkanen
Commentary: Clinical Investigation
-
Antibiotic induced changes to mitochondria result in potential contributions to carcinogenesis.
Jorma Jyrkkanen
Commentary: Clinical Investigation
-
Antibiotic induced changes to mitochondria result in potential contributions to carcinogenesis.
Jorma Jyrkkanen
Commentary: Clinical Investigation
-
Antibiotic induced changes to mitochondria result in potential contributions to carcinogenesis.
Jorma Jyrkkanen
Commentary: Clinical Investigation
-
Antibiotic induced changes to mitochondria result in potential contributions to carcinogenesis.
Jorma Jyrkkanen
Commentary: Clinical Investigation
-
Challenges in incentivizing the pharmaceutical industry to supporting pediatric oncology clinical trials
Paola Angelini, Kathryn Pritchard-Jones & Darren R Hargrave
Editorial: Clinical Investigation
-
Challenges in incentivizing the pharmaceutical industry to supporting pediatric oncology clinical trials
Paola Angelini, Kathryn Pritchard-Jones & Darren R Hargrave
Editorial: Clinical Investigation
-
Challenges in incentivizing the pharmaceutical industry to supporting pediatric oncology clinical trials
Paola Angelini, Kathryn Pritchard-Jones & Darren R Hargrave
Editorial: Clinical Investigation
-
Challenges in incentivizing the pharmaceutical industry to supporting pediatric oncology clinical trials
Paola Angelini, Kathryn Pritchard-Jones & Darren R Hargrave
Editorial: Clinical Investigation
-
Challenges in incentivizing the pharmaceutical industry to supporting pediatric oncology clinical trials
Paola Angelini, Kathryn Pritchard-Jones & Darren R Hargrave
Editorial: Clinical Investigation
-
Challenges in incentivizing the pharmaceutical industry to supporting pediatric oncology clinical trials
Paola Angelini, Kathryn Pritchard-Jones & Darren R Hargrave
Editorial: Clinical Investigation
-
Challenges in incentivizing the pharmaceutical industry to supporting pediatric oncology clinical trials
Paola Angelini, Kathryn Pritchard-Jones & Darren R Hargrave
Editorial: Clinical Investigation
-
Challenges in incentivizing the pharmaceutical industry to supporting pediatric oncology clinical trials
Paola Angelini, Kathryn Pritchard-Jones & Darren R Hargrave
Editorial: Clinical Investigation
-
Opportunities for innovation in the design and execution of clinical trials
John J Orloff, Jeffrey Kralstein
Editorial: Clinical Investigation
-
Opportunities for innovation in the design and execution of clinical trials
John J Orloff, Jeffrey Kralstein
Editorial: Clinical Investigation
-
Opportunities for innovation in the design and execution of clinical trials
John J Orloff, Jeffrey Kralstein
Editorial: Clinical Investigation
-
Opportunities for innovation in the design and execution of clinical trials
John J Orloff, Jeffrey Kralstein
Editorial: Clinical Investigation
-
Opportunities for innovation in the design and execution of clinical trials
John J Orloff, Jeffrey Kralstein
Editorial: Clinical Investigation
-
Opportunities for innovation in the design and execution of clinical trials
John J Orloff, Jeffrey Kralstein
Editorial: Clinical Investigation
-
Opportunities for innovation in the design and execution of clinical trials
John J Orloff, Jeffrey Kralstein
Editorial: Clinical Investigation
-
Opportunities for innovation in the design and execution of clinical trials
John J Orloff, Jeffrey Kralstein
Editorial: Clinical Investigation
-
Investigational drug shows significant improvement in cancer survival rate
News and Views: Clinical Investigation
-
Investigational drug shows significant improvement in cancer survival rate
News and Views: Clinical Investigation
-
Investigational drug shows significant improvement in cancer survival rate
News and Views: Clinical Investigation
-
Investigational drug shows significant improvement in cancer survival rate
News and Views: Clinical Investigation
-
Investigational drug shows significant improvement in cancer survival rate
News and Views: Clinical Investigation
-
Investigational drug shows significant improvement in cancer survival rate
News and Views: Clinical Investigation
-
Investigational drug shows significant improvement in cancer survival rate
News and Views: Clinical Investigation
-
Investigational drug shows significant improvement in cancer survival rate
News and Views: Clinical Investigation
-
Design of clinical trials of antibacterial agents for community-acquired bacterial pneumonia
Brad Spellberg, Roger J Lewis, Helen W Boucher,Eric P Brass
Review Article: Clinical Investigation
-
Design of clinical trials of antibacterial agents for community-acquired bacterial pneumonia
Brad Spellberg, Roger J Lewis, Helen W Boucher,Eric P Brass
Review Article: Clinical Investigation
-
Design of clinical trials of antibacterial agents for community-acquired bacterial pneumonia
Brad Spellberg, Roger J Lewis, Helen W Boucher,Eric P Brass
Review Article: Clinical Investigation
-
Design of clinical trials of antibacterial agents for community-acquired bacterial pneumonia
Brad Spellberg, Roger J Lewis, Helen W Boucher,Eric P Brass
Review Article: Clinical Investigation
-
Design of clinical trials of antibacterial agents for community-acquired bacterial pneumonia
Brad Spellberg, Roger J Lewis, Helen W Boucher,Eric P Brass
Review Article: Clinical Investigation
-
Design of clinical trials of antibacterial agents for community-acquired bacterial pneumonia
Brad Spellberg, Roger J Lewis, Helen W Boucher,Eric P Brass
Review Article: Clinical Investigation
-
Design of clinical trials of antibacterial agents for community-acquired bacterial pneumonia
Brad Spellberg, Roger J Lewis, Helen W Boucher,Eric P Brass
Review Article: Clinical Investigation
-
Design of clinical trials of antibacterial agents for community-acquired bacterial pneumonia
Brad Spellberg, Roger J Lewis, Helen W Boucher,Eric P Brass
Review Article: Clinical Investigation